Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932) : the net profit in the first quarter increased by 295.61% – 324.91% year-on-year
Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932) ( Wuhan Easy Diagnosis Biomedicine Co.Ltd(002932) ) the performance forecast was disclosed on April 13. The net profit in the first quarter is expected to be 1.35-1.45 billion yuan, with a year-on-year increase of 295.61% – 324.91%. Since January 2022, the market share of covid-19 nucleic acid detection reagent of the company has continued to rise, and the income related to covid-19 nucleic acid detection reagent and services has increased significantly. The company has newly approved covid-19 antigen detection kit in China and won the bid in many provinces in China.
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) : Compound Danshen tablets, etc. are proposed to be selected from the collection of Chinese patent medicines of Guangdong alliance
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) ( Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) ) on April 13, it was announced that the company’s products, compound Danshen Tablets and compound Xueshuantong capsules, and the products of South China pharmaceutical, a wholly-owned subsidiary, compound Xueshuantong soft capsules and Naoshuantong capsules, were to be selected for centralized procurement of proprietary Chinese medicines by Guangdong alliance; The wholly-owned subsidiary carboxymethylstein tablets passed the consistency evaluation of generic drug quality and efficacy.
Zhejiang Sanfer Electric Co.Ltd(605336) : the net profit in 2021 increased by 26.95% year-on-year, and it is proposed to allocate 13.9 yuan in 10 shares to increase 3 shares
Zhejiang Sanfer Electric Co.Ltd(605336) ( Zhejiang Sanfer Electric Co.Ltd(605336) ) disclosed the 2021 annual report on April 13, and the company realized an operating revenue of 978 million yuan in 2021, with a year-on-year increase of 36.93%; The net profit attributable to the parent company was 247 million yuan, a year-on-year increase of 26.95%; The basic earnings per share is 1.75 yuan; It is proposed to distribute a cash dividend of 13.9 yuan (including tax) for every 10 shares, and increase 3 shares for every 10 shares to all shareholders with capital reserve.
Hangzhou Toka Ink Co.Ltd(688571) : the net profit in 2021 increased by 3.34% year-on-year, and it is proposed to pay 2 yuan out of 10
Hangzhou Toka Ink Co.Ltd(688571) ( Hangzhou Toka Ink Co.Ltd(688571) ) the annual report of 2021 was released on April 13. In 2021, the company achieved an operating revenue of 1.149 billion yuan, a year-on-year increase of 16.37%; The net profit attributable to the parent company was 113 million yuan, a year-on-year increase of 3.34%; The basic earnings per share is 0.35 yuan; It is proposed to distribute a cash dividend of 2 yuan (including tax) for every 10 shares to all shareholders.
Xinjiang Goldwind Science And Technology Co.Ltd(002202) : it is proposed to invest 18.8 billion yuan in the construction of Wenzhou offshore wind power industry base and other projects
Xinjiang Goldwind Science And Technology Co.Ltd(002202) ( Xinjiang Goldwind Science And Technology Co.Ltd(002202) ) announced on April 13 that the company had established a strategic partnership with Wenzhou municipal government and signed the strategic cooperation framework agreement. The company signed the project investment agreement with the Management Committee of Wenzhou oujiangkou industrial agglomeration zone on matters related to the landing of Xinjiang Goldwind Science And Technology Co.Ltd(002202) Wenzhou far-reaching offshore wind power zero carbon headquarters base and other projects in oujiangkou, and signed the project investment cooperation agreement with Wenzhou Dongtou district government on matters related to building an internationally leading far-reaching offshore equipment manufacturing and service industrial cluster. According to the above agreement, the total investment of the company and other enterprises is about 18.8 billion yuan.
Shenzhen Kangtai Biological Products Co.Ltd(300601) : the net profit in the first quarter increased by 893.93% – 109272% year-on-year
Shenzhen Kangtai Biological Products Co.Ltd(300601) ( Shenzhen Kangtai Biological Products Co.Ltd(300601) ) disclosed the performance forecast on April 13. The net profit in the first quarter was 250300 million yuan, with a year-on-year increase of 893.93% – 109272%. In the first quarter of 2022, sales of quadruple seedlings of main products increased by about 231.35% compared with the same period last year, and sales of hepatitis B vaccine increased by about 33.24% over the same period last year. In addition, compared with the same period last year, the company newly sold 13 price pneumococcal polysaccharide conjugate vaccine, resulting in a significant increase in the company’s net profit compared with the same period last year.
Maxvision Technology Corp(002990) : net profit in the first quarter increased by 49.09% year-on-year
Maxvision Technology Corp(002990) ( Maxvision Technology Corp(002990) ) disclosed the first quarterly report on April 13. In the first quarter, the operating revenue was 261 million yuan, an increase of 46.11% year-on-year; The net profit was 506088 million yuan, a year-on-year increase of 49.09%. The company also disclosed its annual report. In 2021, it achieved a net profit of 179 million yuan, a year-on-year decrease of 20.12%; The basic earnings per share is 0.70 yuan. The company plans to distribute a cash dividend of 2 yuan (including tax) for every 10 shares.
Livzon Pharmaceutical Group Inc(000513) : Li Zhu reagent New Coronavirus antigen detection kit (latex method) approved for listing
Livzon Pharmaceutical Group Inc(000513) ( Livzon Pharmaceutical Group Inc(000513) ) announced in April 13th that the New Coronavirus (2019-nCoV) antigen detection kit (latex method), which was independently developed by Affiliated Companies Zhuhai Li Zhu reagent Limited by Share Ltd, was approved and registered by the State Drug Administration.
Jiangxi Special Electric Motor Co.Ltd(002176) : net profit in the first quarter increased 760.96% – 829.29% year-on-year
Jiangxi Special Electric Motor Co.Ltd(002176) ( Jiangxi Special Electric Motor Co.Ltd(002176) ) disclosed the performance forecast on April 13. It is estimated that the net profit in the first quarter is 630 million yuan – 680 million yuan, with a year-on-year increase of 760.96% – 829.29%. During the reporting period, the external environment of lithium salt business continued to improve, the demand of downstream customers for lithium salt increased, the price of lithium salt products increased significantly, and the profit of the company’s lithium salt industry increased significantly compared with the same period of last year.
Shandong Jinling Mining Co.Ltd(000655) : the net profit in the first quarter is expected to decrease by 52.59% – 62.89% year-on-year
Shandong Jinling Mining Co.Ltd(000655) ( Shandong Jinling Mining Co.Ltd(000655) ) the performance forecast was disclosed on April 13, and the net profit in the first quarter is expected to be 36 million yuan – 46 million yuan, a year-on-year decrease of 52.59% – 62.89%. The main reasons for the decline in performance: first, the sales volume and price of iron concentrate powder, the main product of the parent company, decreased year-on-year; Second, the investment income of the parent company in the associated enterprise Shandong Jinding Mining Co., Ltd. decreased compared with the same period of last year.
